-
There was no evidence of significant benefit from the administration of the antiviral agent, celgosivir, in the treatment of patients with dengue fever.
-
A 58-year-old woman from Southern Australia with a history of medically-managed liver abscess eight months prior to admission and recurrent urinary tract infections presented to our hospital with two weeks of fever and right upper quadrant.
-
As the first cases of Ebola ever treated in the U.S. were recently admitted to a special containment unit at Emory University Hospital in Atlanta, clinicians and public health officials continued to reassure a jittery public that infection control measures would prevent transmission and contain the virus.
-
A series of biosafety breaches in federal labs working with highly pathogenic agents has created a rift in the research community, with some calling for a moratorium until safety can be assured and other scientists arguing that this important work should continue with appropriate precautions to prepare for pandemics and bioterror attacks.
-
-
A prospective case series that included patients with recurrent Clostridium difficile infection found that treatment with tapered antibiotic therapy and the probiotic drink kefir resulted in a clinical cure of 84% (21 out of 25 patients).
-
Approximately half of blood cultures taken from febrile infants with bacteremia turn positive within 15 hours of sampling.
-
With sincere apologies to the ghost of Winston Churchill, never in the field of infection prevention was so much purchased by so many to be worn by so few.
-
While infection preventionists in the nations hospitals are diverting time and resources to Ebola preparedness there is a real risk that a host of other infections from Clostridium difficile to MRSA will increase and claim many more American lives than the highly publicized virus out of West Africa.
-
While it has been duly noted that many hospitals lack the surge capacity and training to deal with an Ebola patient, the public health system is also ill prepared for emerging infectious disease outbreaks and pandemics, an expert in the field warns.